College of American Pathologists
CAP Committees & Leadership CAP Calendar of Events Estore CAP Media Center CAP Foundation
About CAP    Career Center    Contact Us      
Search: Search
  [Advanced Search]  
CAP Home CAP Advocacy CAP Reference Resources and Publications CAP Education Programs CAP Accreditation and Laboratory Improvement CAP Members
CAP Home > CAP Reference Resources and Publications > CAP TODAY > CAP Today Archive 2001 > The New Rule At A Glance
Printable Version



cap today

The New Rule At A Glance

Back to Feature Story

April 2001

  • Transfusion services must report to the FDA any biological product deviation associated with the manufacturing of blood components if the event occurred while the product was under their control and was then released to a patient.
  • Biological product deviation reports must be filed as soon as possible but no later than 45 days from the date of discovery of the possible deviation.
  • Biological product deviation reports will be subject to public disclosure under the provisions of the 1966 Freedom of Information Act.



 © 2014 College of American Pathologists. All rights reserved. | Terms and Conditions | CAP ConnectFollow Us on FacebookFollow Us on LinkedInFollow Us on TwitterFollow Us on YouTubeFollow Us on FlickrSubscribe to a CAP RSS Feed